[go: up one dir, main page]

Bialer et al., 1984 - Google Patents

Pharmacokinetics of valpromide in dogs after various modes of administration

Bialer et al., 1984

Document ID
8183937658491529788
Author
Bialer M
Rubinstein A
Publication year
Publication venue
Biopharmaceutics & drug disposition

External Links

Snippet

Valpromide‐Depropylacetamide was administered to five dogs via five modes: Three oral formulations (solution, capsule, and enteric‐coated tablet), intravenous and intra‐muscular injections. No significant change in the terminal half‐life of valpromide could be observed …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Porte A receptor mechanism for the inhibition of insulin release by epinephrine in man
Karbwang et al. Clinical pharmacokinetics of mefloquine
HADDAD Jr et al. Acute administration of 25-hydroxycholecalciferol in man
Fromenty et al. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
Graffner et al. Pharmacokinetics of procainamide intravenously and orally as conventional and slow‐release tablets
Pourbaix et al. Absolute bioavailability of amiodarone in normal subjects
Kragh-Sorensen et al. Plasma levels of nortriptyline in the treatment of endogenous depression.
Ward et al. Pharmacokinetics of atracurium and its metabolites
Johnston et al. Systemic availability of oral verapamil and effect on PR interval in man.
Bialer et al. Pharmacokinetics of valpromide in dogs after various modes of administration
Offerhaus et al. Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers
Galenko-Yaroshevsky et al. Pharmacokinetic studies derived indole SS-68 with antiarrhythmic and antianginal properties
Rubin et al. Physiological disposition of fenoprofen in man II: Plasma and urine pharmacokinetics after oral and intravenous administration
Tognoni et al. Pharmacokinetics of N‐demethyldiazepam in patients suffering from insomnia and treated with nortriptyline.
Wing et al. The effect of metoclopramide and atropine on the absorption of orally administered mexiletine
Loi et al. Inhibition of theophylline metabolism by mexiletine in young male and female nonsmokers
Merkus et al. Pharmacokinetics of spironolactone after a single dose: evaluation of the true canrenone serum concentrations during 24 hours
Tang et al. Radiosynthesis and preliminary biological evaluation of N-(2-[18F] fluoropropionyl)-L-glutamine as a PET tracer for tumor imaging
Polyakov et al. Peculiarities of pharmacokinetics and bioavailability of some cardiovascular drugs under conditions of antiorthostatic hypokinesia
Pisani et al. Effect of valpromide on the pharmacokinetics of carbamazepine‐10, 11‐epoxide.
Szutu et al. Pharmacokinetics of intravenous clomiphene isomers
Haj-Yehia et al. Pharmacokinetics of a valpromide isomer, valnoctamide, in dogs
Braden et al. Hemodynamic, cardiac, and electrolyte effects of low-dose aerosolized terbutaline sulfate in asthmatic patients
Rosseel et al. Meptazinol (Wy 22811), a new analgesic: preliminary pharmacokinetic data
Pisani et al. Increased dipropylacetic acid bioavailability from dipropylacetamide by food